All In Biotech

Drug Trial Radar · NCT00312494

3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects

A Three-Week, Double-Blind, Multicenter, Placebo-Controlled Study Evaluating the Efficacy and Safety of Add-On Oral Ziprasidone in Subjects With Acute Mania Treated With Lithium or Divalproex

Last checked: Nov 20, 2026Latest source record: Mar 29, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 680 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

680

Actual

Start

Apr 2006

Primary completion

Dec 2008

Study completion Dec 2008

Sponsor

Sponsor type
Industry
First posted
Apr 10, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

3-week study to evaluate efficacy and safety of ziprasidone with either lithium or divalproex in acutely manic subjects

Conditions

  • Bipolar Disorder

Interventions

  • PlaceboDrug

    Placebo with mood stabilizer (either lithium or divalproex)

  • ZiprasidoneDrug

    Flexible dosing, 20-40mg BID, with a mood stabilizer (either lithium or divalproex)

  • ZiprasidoneDrug

    Flexible dosing, 60-80mg BID, with a mood stabilizer (either lithium or divalproex)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to Week 3 in Young Mania Rating Scale (YMRS)Time frame: Baseline, Week 3

Locations

66 sites in 1 country. Site status is shown where the registry gives one.

  • Pfizer Investigational Site

    Dothan, Alabama

  • Pfizer Investigational Site

    Scottsdale, Arizona

  • Pfizer Investigational Site

    Little Rock, Arkansas

  • Pfizer Investigational Site

    Cerritos, California

  • Pfizer Investigational Site

    Costa Mesa, California

  • Pfizer Investigational Site

    Escondido, California

  • Pfizer Investigational Site

    Glendale, California

  • Pfizer Investigational Site

    Huntington Beach, California

  • Pfizer Investigational Site

    Los Angeles, California

  • Pfizer Investigational Site

    Los Angeles, California

  • Pfizer Investigational Site

    National City, California

  • Pfizer Investigational Site

    Oceanside, California

  • Pfizer Investigational Site

    San Diego, California

  • Pfizer Investigational Site

    San Diego, California

  • Pfizer Investigational Site

    San Diego, California

  • Pfizer Investigational Site

    Torrance, California

  • Pfizer Investigational Site

    Hartford, Connecticut

  • Pfizer Investigational Site

    New Britain, Connecticut

  • Pfizer Investigational Site

    DeLand, Florida

  • Pfizer Investigational Site

    Fort Lauderdale, Florida

  • Pfizer Investigational Site

    Fort Lauderdale, Florida

  • Pfizer Investigational Site

    Gainesville, Florida

  • Pfizer Investigational Site

    Hollywood, Florida

  • Pfizer Investigational Site

    Jacksonville, Florida

  • Pfizer Investigational Site

    Lauderhill, Florida

  • Pfizer Investigational Site

    North Miami, Florida

  • Pfizer Investigational Site

    Atlanta, Georgia

  • Pfizer Investigational Site

    Honolulu, Hawaii

  • Pfizer Investigational Site

    Des Plaines, Illinois

  • Pfizer Investigational Site

    Hoffman Estates, Illinois

  • Pfizer Investigational Site

    Hoffman Estates, Illinois

  • Pfizer Investigational Site

    Schaumburg, Illinois

  • Pfizer Investigational Site

    Greenwood, Indiana

  • Pfizer Investigational Site

    Prairie Village, Kansas

  • Pfizer Investigational Site

    Glen Burnie, Maryland

  • Pfizer Investigational Site

    Flowood, Mississippi

  • Pfizer Investigational Site

    Kansas City, Missouri

  • Pfizer Investigational Site

    Saint Charles, Missouri

  • Pfizer Investigational Site

    St Louis, Missouri

  • Pfizer Investigational Site

    St Louis, Missouri

Showing 40 of 66 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.